World's Best Scientists 2026 revealed!
Junji Furuse

Junji Furuse

D-Index & Metrics

Medicine

D-Index
80
Citations
30522
World Ranking
16939
National Ranking
534

Overview

Junji Furuse is affiliated with Kyorin University in Japan and has contributed extensively to the field of Medicine, focusing primarily on Oncology. Their work spans subfields such as Surgery, Pulmonary and Respiratory Medicine, Hepatology, and Epidemiology.

Their research concentrates on several main topics including Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Hepatocellular Carcinoma Treatment and Prognosis, Neuroendocrine Tumor Research Advances, Cancer Genomics and Diagnostics, Gallbladder and Bile Duct Disorders, and Colorectal Cancer Treatments and Studies.

Junji Furuse has published numerous papers, with notable recent works being:

  • "Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma" (2022, NEJM Evidence)
  • "Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial" (2023, The Lancet)
  • "Futibatinib for FGFR2 -Rearranged Intrahepatic Cholangiocarcinoma" (2023, New England Journal of Medicine)
  • "Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma" (2020, Journal of Hepatology)
  • "Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA." (2022, Journal of Clinical Oncology)

The scientist often collaborates with other researchers, including frequent co-authors such as Masafumi Ikeda, Makoto Ueno, Takuji Okusaka, Masato Ozaka, and Chigusa Morizane.

Their work is regularly published in high-impact journals, with common venues for their publications being:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • Journal of Hepato-Biliary-Pancreatic Sciences
  • Japanese Journal of Clinical Oncology
  • Pancreatology

Best Publications

  • Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

    Kohei Shitara;Mustafa Özgüroğlu;Yung-Jue Bang;Maria Di Bartolomeo

  • The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective

    Alan P. Venook;Christos Papandreou;Junji Furuse;Laura Ladrón de Guevara

  • Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

    T Okusaka;K Nakachi;A Fukutomi;N Mizuno

  • Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study

    Hideki Ueno;Tatsuya Ioka;Masafumi Ikeda;Shinichi Ohkawa

  • Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma.

    Masatoshi Kudo;Kazuho Imanaka;Nobuyuki Chida;Kohei Nakachi

  • Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.

    Andrew X. Zhu;Masatoshi Kudo;Eric Assenat;Stéphane Cattan

  • Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.

    Masatoshi Kudo;Kazuomi Ueshima;Masafumi Ikeda;Takuji Torimura

  • Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study

    Hedy L Kindler;Tatsuya Ioka;Dirk J Richel;Jaafar Bennouna

  • Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

    Juan W Valle;J Furuse;M Jitlal;S Beare

  • Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)

    Fuyuhiko Motoi;Tomoo Kosuge;Hideki Ueno;Hiroki Yamaue

  • Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study

    Jorge A. Marrero;Masatoshi Kudo;Alan P. Venook;Sheng Long Ye

  • Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies.

    Yoshiaki Nakamura;Hiroya Taniguchi;Masafumi Ikeda;Hideaki Bando

  • Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival.

    Yu Sawada;Toshiaki Yoshikawa;Daisuke Nobuoka;Hirofumi Shirakawa

  • Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma

    Bruno Sangro;Ignacio Melero;Samir Wadhawan;Richard S Finn

  • Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition

    Masaru Miyazaki;Hideyuki Yoshitomi;Shuichi Miyakawa;Katsuhiko Uesaka

  • Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study

    Makoto Ueno;Masafumi Ikeda;Chigusa Morizane;Satoshi Kobayashi

  • GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

    R. Lencioni;M. Kudo;S. L. Ye;J. P. Bronowicki

  • Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

    Masafumi Ikeda;Chigusa Morizane;Makoto Ueno;Takuji Okusaka

  • Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment

    Satoshi Kondo;Tadahiro Takada;Masaru Miyazaki;Shuichi Miyakawa

  • Phase II Study of Radiotherapy Employing Proton Beam for Hepatocellular Carcinoma

    Mitsuhiko Kawashima;Junji Furuse;Teiji Nishio;Masaru Konishi

Frequent Co-Authors

Takuji Okusaka
Takuji Okusaka National Cancer Centre
Masatoshi Kudo
Masatoshi Kudo Kindai University
Narikazu Boku
Narikazu Boku St. Marianna University School of Medicine
Shoji Nakamori
Shoji Nakamori Osaka University
Juan W. Valle
Juan W. Valle University of Manchester
Masaru Miyazaki
Masaru Miyazaki International University of Health and Welfare
Tadatoshi Takayama
Tadatoshi Takayama Nihon University
Shuichi Kaneko
Shuichi Kaneko Kanazawa University
Jun-ichi Sawada
Jun-ichi Sawada University of Shizuoka

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in studying Medicine in the USA, several online degrees and certifications can broaden your career options in healthcare. One popular area is online nutrition degrees, which prepare graduates to work in wellness, dietetics, and public health. This pathway is ideal for those who wish to help others improve their health through dietary and lifestyle changes.

Management roles in healthcare are also in high demand. Completing a cahme-accredited Master of Healthcare Administration (MHA) program online can help launch a career in hospital leadership, health systems management, or clinic administration.

For current registered nurses, flexible options like rn to bsn with no clinicals programs offer a way to advance qualifications without the need for in-person clinical components. This makes it easier to gain new skills while continuing to work.

Those aiming for advanced practice or executive roles should explore the shortest msn to dnp program offerings. These online programs help nurses quickly earn terminal degrees and qualify for top positions in practice, education, or administration.

Best Scientists Citing Junji Furuse

Trending Scientists

Recently Published Articles